95 related articles for article (PubMed ID: 25453800)
61. Synthesis, Characterization, and Biological Evaluations of 1,3,5-Triazine Derivatives of Metformin Cyclization with Berberine and Magnolol in the Presence of Sodium Methylate.
Cao H; Liao S; Zhong W; Xiao X; Zhu J; Li W; Wu X; Feng Y
Molecules; 2017 Oct; 22(10):. PubMed ID: 29057810
[TBL] [Abstract][Full Text] [Related]
62. Pyrazolotriazines: Biological activities, synthetic strategies and recent developments.
Alizadeh SR; Ebrahimzadeh MA
Eur J Med Chem; 2021 Nov; 223():113537. PubMed ID: 34147747
[TBL] [Abstract][Full Text] [Related]
63. Synthesis, structure determination, and biological evaluation of phenylsulfonyl hydrazide derivatives as potential anti-inflammatory agents.
Park EB; Kim KJ; Jeong HR; Lee JK; Kim HJ; Lee HH; Lim JW; Shin JS; Koeberle A; Werz O; Lee KT; Lee JY
Bioorg Med Chem Lett; 2016 Nov; 26(21):5193-5197. PubMed ID: 27720548
[TBL] [Abstract][Full Text] [Related]
64. Synthetic and pharmacological developments in the hybrid s-triazine moiety: A review.
Bareth D; Jain S; Kumawat J; Kishore D; Dwivedi J; Hashmi SZ
Bioorg Chem; 2024 Feb; 143():106971. PubMed ID: 38016395
[TBL] [Abstract][Full Text] [Related]
65. Anti-inflammatory activity of triazine derivatives: A systematic review.
Marín-Ocampo L; Veloza LA; Abonia R; Sepúlveda-Arias JC
Eur J Med Chem; 2019 Jan; 162():435-447. PubMed ID: 30469039
[TBL] [Abstract][Full Text] [Related]
66. Design, synthesis and biological evaluation of 2,4,6- trisubstituted triazine derivatives as new nonpeptide small-molecule SIRT5 inhibitors.
Wang L; Hu L; Deng J; Hou S; Mou L; Lei P; Chen X; Liu J; Jiang Y; Xiong R; Tian X; Zhang W; Li R; Yang W; Yang L
Bioorg Med Chem; 2023 Oct; 93():117455. PubMed ID: 37643500
[TBL] [Abstract][Full Text] [Related]
67. Antioxidative Activity of 1,3,5-Triazine Analogues Incorporating Aminobenzene Sulfonamide, Aminoalcohol/Phenol, Piperazine, Chalcone, or Stilbene Motifs.
Havránková E; Čalkovská N; Padrtová T; Csöllei J; Opatřilová R; Pazdera P
Molecules; 2020 Apr; 25(8):. PubMed ID: 32295147
[TBL] [Abstract][Full Text] [Related]
68. [Pharmacological studies of triazine derivatives. II. Psychotropic actions of 2-amino-4-substituted-6-trifluoromethyl-s-triazine derivatives (author's transl)].
Tobe A; Tsunoda M
Yakugaku Zasshi; 1976 Mar; 96(3):370-80. PubMed ID: 986454
[No Abstract] [Full Text] [Related]
69.
Dubey P; Pathak DP; Ali F; Chauhan G; Kalaiselvan V
Curr Drug Discov Technol; 2024; 21(2):e170723218813. PubMed ID: 37461340
[TBL] [Abstract][Full Text] [Related]
70. Design and Development of COX-II Inhibitors: Current Scenario and Future Perspective.
Chahal S; Rani P; Kiran ; Sindhu J; Joshi G; Ganesan A; Kalyaanamoorthy S; Mayank ; Kumar P; Singh R; Negi A
ACS Omega; 2023 May; 8(20):17446-17498. PubMed ID: 37251190
[TBL] [Abstract][Full Text] [Related]
71. Targeting microsomal prostaglandin E synthase 1 to develop drugs treating the inflammatory diseases.
Wang Q; Li Y; Wu M; Huang S; Zhang A; Zhang Y; Jia Z
Am J Transl Res; 2021; 13(1):391-419. PubMed ID: 33527033
[TBL] [Abstract][Full Text] [Related]
72. Effect of Ultrafine Powderization and Solid Dispersion Formation via Hot-Melt Extrusion on Antioxidant, Anti-Inflammatory, and the Human Kv1.3 Channel Inhibitory Activities of
Jiang Y; Piao J; Liu N; Hou J; Liu J; Hu W
Bioinorg Chem Appl; 2020; 2020():7846176. PubMed ID: 32952541
[No Abstract] [Full Text] [Related]
73. Effects of AF3442 [N-(9-ethyl-9H-carbazol-3-yl)-2-(trifluoromethyl)benzamide], a novel inhibitor of human microsomal prostaglandin E synthase-1, on prostanoid biosynthesis in human monocytes in vitro.
Bruno A; Di Francesco L; Coletta I; Mangano G; Alisi MA; Polenzani L; Milanese C; Anzellotti P; Ricciotti E; Dovizio M; Di Francesco A; Tacconelli S; Capone ML; Patrignani P
Biochem Pharmacol; 2010 Apr; 79(7):974-81. PubMed ID: 19925781
[TBL] [Abstract][Full Text] [Related]
74. Hit-to-lead optimization of phenylsulfonyl hydrazides for a potent suppressor of PGE2 production: Synthesis, biological activity, and molecular docking study.
Kim M; Lee S; Park EB; Kim KJ; Lee HH; Shin JS; Fischer K; Koeberle A; Werz O; Lee KT; Lee JY
Bioorg Med Chem Lett; 2016 Jan; 26(1):94-9. PubMed ID: 26602278
[TBL] [Abstract][Full Text] [Related]
75. Membrane prostaglandin E synthase-1: a novel therapeutic target.
Samuelsson B; Morgenstern R; Jakobsson PJ
Pharmacol Rev; 2007 Sep; 59(3):207-24. PubMed ID: 17878511
[TBL] [Abstract][Full Text] [Related]
76. Microsomal prostaglandin E synthase-1 and 5-lipoxygenase: potential drug targets in cancer.
Rådmark O; Samuelsson B
J Intern Med; 2010 Jul; 268(1):5-14. PubMed ID: 20497297
[TBL] [Abstract][Full Text] [Related]
77. Synthesis and PGE₂ production inhibition of s-triazine derivatives as a novel scaffold in RAW 264.7 macrophage cells.
Kang SM; Lee J; Jin JH; Kim M; Lee S; Lee HH; Shin JS; Lee KT; Lee JY
Bioorg Med Chem Lett; 2014 Dec; 24(23):5418-22. PubMed ID: 25453800
[TBL] [Abstract][Full Text] [Related]
78. Identification of novel mPGES-1 inhibitors through screening of a chemical library.
Park SJ; Han SG; Ahsan HM; Lee K; Lee JY; Shin JS; Lee KT; Kang NS; Yu YG
Bioorg Med Chem Lett; 2012 Dec; 22(24):7335-9. PubMed ID: 23147075
[TBL] [Abstract][Full Text] [Related]
79.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
80.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
